For Immediate Release:
AURORA, CO – May 1, 2017 — Galaxy Ophthalmics, LLC today announced it has appointed Dr. Bruce Eaton to its Board of Directors. A 35-year veteran of the pharmaceutical and diagnostics industry, Dr. Eaton brings a pool of knowledge that is both deep and broad to the Galaxy Ophthalmics team. His appointment is effective immediately.
“We are fortunate to have Dr. Eaton join with us in providing relief to people suffering from Ophthalmic Diseases. He brings a wealth of proven business and technology leadership experience,” states Fred Mitchell, CEO of Galaxy. “We are extremely pleased that he is joining Galaxy’s board.”
About Galaxy Ophthalmics, LLC
Galaxy Ophthalmics is an early stage company developing products addressing Age-Related Macular Degeneration and Glaucoma, the leading causes of blindness.